238 related articles for article (PubMed ID: 37717596)
21. Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
Wheeler FJ; Nigg DW; Capala J; Watkins PR; Vroegindeweij C; Auterinen I; Seppälä T; Bleuel D
Med Phys; 1999 Jul; 26(7):1237-44. PubMed ID: 10435523
[TBL] [Abstract][Full Text] [Related]
22. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
[TBL] [Abstract][Full Text] [Related]
23. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M
Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337
[TBL] [Abstract][Full Text] [Related]
24. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
25. Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma.
Kanno H; Nagata H; Ishiguro A; Tsuzuranuki S; Nakano S; Nonaka T; Kiyohara K; Kimura T; Sugawara A; Okazaki Y; Takae S; Nakabayashi T; Arai H; Suzuki H
Oncologist; 2021 Jul; 26(7):e1250-e1255. PubMed ID: 33928712
[TBL] [Abstract][Full Text] [Related]
26. Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era.
Suzuki M
Int J Clin Oncol; 2020 Jan; 25(1):43-50. PubMed ID: 31168726
[TBL] [Abstract][Full Text] [Related]
27. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
[TBL] [Abstract][Full Text] [Related]
28. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
[TBL] [Abstract][Full Text] [Related]
29. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
Wang P; Zhen H; Jiang X; Zhang W; Cheng X; Guo G; Mao X; Zhang X
BMC Cancer; 2010 Dec; 10():661. PubMed ID: 21122152
[TBL] [Abstract][Full Text] [Related]
30. Boron delivery agents for neutron capture therapy of cancer.
Barth RF; Mi P; Yang W
Cancer Commun (Lond); 2018 Jun; 38(1):35. PubMed ID: 29914561
[TBL] [Abstract][Full Text] [Related]
31. Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model.
Garabalino MA; Monti Hughes A; Molinari AJ; Heber EM; Pozzi EC; Cardoso JE; Colombo LL; Nievas S; Nigg DW; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Radiat Environ Biophys; 2011 Mar; 50(1):199-207. PubMed ID: 21132507
[TBL] [Abstract][Full Text] [Related]
32. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
33. Strategies for Preclinical Studies Evaluating the Biological Effects of an Accelerator-Based Boron Neutron Capture Therapy System.
Kondo N; Masutani M; Imamichi S; Matsumoto Y; Nakai K
Cancer Biother Radiopharm; 2023 Apr; 38(3):173-183. PubMed ID: 36154293
[TBL] [Abstract][Full Text] [Related]
34. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.
Luderer MJ; de la Puente P; Azab AK
Pharm Res; 2015 Sep; 32(9):2824-36. PubMed ID: 26033767
[TBL] [Abstract][Full Text] [Related]
35. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
37. Boronated compounds for imaging guided BNCT applications.
Geninatti-Crich S; Deagostino A; Toppino A; Alberti D; Venturello P; Aime S
Anticancer Agents Med Chem; 2012 Jun; 12(5):543-53. PubMed ID: 22263798
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic Study of
Watanabe T; Yoshikawa T; Tanaka H; Kinashi Y; Kashino G; Masunaga SI; Hayashi T; Uehara K; Ono K; Suzuki M
Eur J Drug Metab Pharmacokinet; 2023 Jul; 48(4):443-453. PubMed ID: 37198368
[TBL] [Abstract][Full Text] [Related]
39. Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor.
Wang LW; Liu YH; Chou FI; Jiang SH
Cancer Commun (Lond); 2018 Jun; 38(1):37. PubMed ID: 29914577
[TBL] [Abstract][Full Text] [Related]
40. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
